domingo, 28 de marzo de 2021

Managing patients with rheumatic diseases treated with rituximab during the COVID-19 pandemic - The Lancet Rheumatology

Managing patients with rheumatic diseases treated with rituximab during the COVID-19 pandemic - The Lancet Rheumatology

No hay comentarios:

Publicar un comentario